Literature DB >> 25158193

Big endothelin changes the cellular miRNA environment in TMOb osteoblasts and increases mineralization.

Michael G Johnson1, Jasmin Kristianto, Baozhi Yuan, Kathryn Konicke, Robert Blank.   

Abstract

INTRODUCTION: Endothelin (ET1) promotes the growth of osteoblastic breast and prostate cancer metastases. Conversion of big ET1 to mature ET1, catalyzed primarily by endothelin converting enzyme 1 (ECE1), is necessary for ET1's biological activity. We previously identified the Ece1, locus as a positional candidate gene for a pleiotropic quantitative trait locus affecting femoral size, shape, mineralization, and biomechanical performance.
METHODS: We exposed TMOb osteoblasts continuously to 25 ng/ml big ET1. Cells were grown for 6 days in growth medium and then switched to mineralization medium for an additional 15 days with or without big ET1, by which time the TMOb cells form mineralized nodules. We quantified mineralization by alizarin red staining and analyzed levels of miRNAs known to affect osteogenesis. Micro RNA 126-3p was identified by search as a potential regulator of sclerostin (SOST) translation.
RESULTS: TMOb cells exposed to big ET1 showed greater mineralization than control cells. Big ET1 repressed miRNAs targeting transcripts of osteogenic proteins. Big ET1 increased expression of miRNAs that target transcripts of proteins that inhibit osteogenesis. Big ET1 increased expression of 126-3p 121-fold versus control. To begin to assess the effect of big ET1 on SOST production we analyzed both SOST transcription and protein production with and without the presence of big ET1 demonstrating that transcription and translation were uncoupled.
CONCLUSION: Our data show that big ET1 signaling promotes mineralization. Moreover, the results suggest that big ET1's osteogenic effects are potentially mediated through changes in miRNA expression, a previously unrecognized big ET1 osteogenic mechanism.

Entities:  

Keywords:  Anabolic activity; mineralization; osteoblasts; osteogenesis; signaling

Mesh:

Substances:

Year:  2014        PMID: 25158193      PMCID: PMC4640685          DOI: 10.3109/03008207.2014.923866

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  15 in total

1.  New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade.

Authors:  J B Nelson; S H Nguyen; J R Wu-Wong; T J Opgenorth; D B Dixon; L W Chung; N Inoue
Journal:  Urology       Date:  1999-05       Impact factor: 2.649

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 3.  Sclerostin and Wnt signaling--the pathway to bone strength.

Authors:  Susan M Ott
Journal:  J Clin Endocrinol Metab       Date:  2005-12       Impact factor: 5.958

4.  Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.

Authors:  Xiaofeng Li; Yazhou Zhang; Heeseog Kang; Wenzhong Liu; Peng Liu; Jianghong Zhang; Stephen E Harris; Dianqing Wu
Journal:  J Biol Chem       Date:  2005-03-18       Impact factor: 5.157

5.  A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases.

Authors:  Juan Juan Yin; Khalid S Mohammad; Sanna M Käkönen; Stephen Harris; J Ruth Wu-Wong; Jerry L Wessale; Robert J Padley; I Ross Garrett; John M Chirgwin; Theresa A Guise
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-26       Impact factor: 11.205

6.  Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate.

Authors:  J B Nelson; S P Hedican; D J George; A H Reddi; S Piantadosi; M A Eisenberger; J W Simons
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

7.  A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels.

Authors:  M Yanagisawa; H Kurihara; S Kimura; K Goto; T Masaki
Journal:  J Hypertens Suppl       Date:  1988-12

8.  Intrinsic mineralization defect in Hyp mouse osteoblasts.

Authors:  Z S Xiao; M Crenshaw; R Guo; T Nesbitt; M K Drezner; L D Quarles
Journal:  Am J Physiol       Date:  1998-10

9.  miRBase: microRNA sequences, targets and gene nomenclature.

Authors:  Sam Griffiths-Jones; Russell J Grocock; Stijn van Dongen; Alex Bateman; Anton J Enright
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

10.  Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption.

Authors:  J W Chiao; B S Moonga; Y M Yang; R Kancherla; A Mittelman; J R Wu-Wong; T Ahmed
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

View more
  7 in total

Review 1.  Cross-talk of MicroRNA and hydrogen sulfide: A novel therapeutic approach for bone diseases.

Authors:  Yuankun Zhai; Suresh C Tyagi; Neetu Tyagi
Journal:  Biomed Pharmacother       Date:  2017-06-10       Impact factor: 6.529

Review 2.  Endothelin Signaling in Bone.

Authors:  Jasmin Kristianto; Michael G Johnson; Rafia Afzal; Robert D Blank
Journal:  Endocrinol Metab Clin North Am       Date:  2016-11-26       Impact factor: 4.741

3.  Role of Endothelin-1 in a Syndrome of Myelofibrosis and Osteosclerosis.

Authors:  Ralph Yachoui; Jasmin Kristianto; Kajal Sitwala; Robert D Blank
Journal:  J Clin Endocrinol Metab       Date:  2015-09-10       Impact factor: 5.958

4.  Combined exposure to big endothelin-1 and mechanical loading in bovine sternal cores promotes osteogenesis.

Authors:  Luisa A Meyer; Michael G Johnson; Diane M Cullen; Juan F Vivanco; Robert D Blank; Heidi-Lynn Ploeg; Everett L Smith
Journal:  Bone       Date:  2016-02-12       Impact factor: 4.398

5.  Endothelin signaling regulates mineralization and posttranscriptionally regulates SOST in TMOb cells via miR 126-3p.

Authors:  Michael G Johnson; Kathryn Konicke; Jasmin Kristianto; Anne Gustavson; Rachel Garbo; Xiaohu Wang; Baozhi Yuan; Robert D Blank
Journal:  Physiol Rep       Date:  2017-02

6.  Zebrafish otolith biomineralization requires polyketide synthase.

Authors:  Kevin D Thiessen; Steven J Grzegorski; Yvonne Chin; Lisa N Higuchi; Christopher J Wilkinson; Jordan A Shavit; Kenneth L Kramer
Journal:  Mech Dev       Date:  2019-04-08       Impact factor: 1.882

7.  The -839(A/C) Polymorphism in the ECE1 Isoform b Promoter Associates With Osteoporosis and Fractures.

Authors:  Karen E Hansen; Michael G Johnson; Tonia C Carter; John Mayer; Nicholas S Keuler; Robert D Blank
Journal:  J Endocr Soc       Date:  2019-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.